18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267 Anatomic Stage ...
Clinical Stage ...
Glioma
Malignant Brain...
Metastatic Brea...
Metastatic Colo...
Metastatic Kidn...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Pathologic Stag...
Prognostic Stag...
Stage IV Colon ...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Lung ...
Stage IVB Colon...
Stage IVB Lung ...
Stage IVC Colon...
Computed Tomogr...
18F-FMAU
Multiparametric...
Positron Emissi...
18 Years - University of Southern California View Cancer Genetic Testing in Ethnic Populations NCT04475640 Breast Carcinom...
Carcinoma of Un...
Central Nervous...
Digestive Syste...
Genitourinary S...
Head and Neck C...
Malignant Brain...
Malignant Femal...
Malignant Muscu...
Malignant Solid...
Skin Carcinoma
Biospecimen Col...
Genetic Testing
18 Years - Mayo Clinic View Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers NCT04459273 Bladder Carcino...
Cervical Carcin...
Cholangiocarcin...
Hematopoietic a...
Hepatocellular ...
Malignant Adren...
Malignant Brain...
Malignant Pleur...
Malignant Skin ...
Malignant Solid...
Malignant Testi...
Malignant Thymu...
Neuroendocrine ...
Thyroid Gland C...
Urothelial Carc...
Cancer of Unkno...
Computed Tomogr...
Gallium Ga 68 F...
Positron Emissi...
18F-FDG
18 Years - Jonsson Comprehensive Cancer Center View Feasibility of FMISO in Brain Tumors NCT03649880 Malignant Brain...
¹⁸F-Fluoromison...
Computed Tomogr...
Magnetic Resona...
Positron Emissi...
Oxygen Therapy
18 Years - OHSU Knight Cancer Institute View Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery NCT03510208 Malignant Brain...
Malignant Gliom...
Near-Infrared F...
Panitumumab
Panitumumab-IRD...
POINPOINT-IR900...
18 Years - Stanford University View Feasibility of FMISO in Brain Tumors NCT03649880 Malignant Brain...
¹⁸F-Fluoromison...
Computed Tomogr...
Magnetic Resona...
Positron Emissi...
Oxygen Therapy
18 Years - OHSU Knight Cancer Institute View Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study NCT04456140 Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic View Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study NCT04456140 Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic View Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study NCT04456140 Breast Carcinom...
Digestive Syste...
Malignant Brain...
Malignant Centr...
Malignant Femal...
Malignant Genit...
Malignant Head ...
Malignant Muscu...
Malignant Solid...
Metastatic Mali...
Skin Carcinoma
Biospecimen Col...
Genetic Counsel...
Genetic Testing
Survey Administ...
18 Years - Mayo Clinic View 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267 Anatomic Stage ...
Clinical Stage ...
Glioma
Malignant Brain...
Metastatic Brea...
Metastatic Colo...
Metastatic Kidn...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Pathologic Stag...
Prognostic Stag...
Stage IV Colon ...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Lung ...
Stage IVB Colon...
Stage IVB Lung ...
Stage IVC Colon...
Computed Tomogr...
18F-FMAU
Multiparametric...
Positron Emissi...
18 Years - University of Southern California View Feasibility of FMISO in Brain Tumors NCT03649880 Malignant Brain...
¹⁸F-Fluoromison...
Computed Tomogr...
Magnetic Resona...
Positron Emissi...
Oxygen Therapy
18 Years - OHSU Knight Cancer Institute View CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children NCT04510051 Malignant Brain...
Recurrent Malig...
Refractory Mali...
Cyclophosphamid...
Fludarabine
IL13Ralpha2-spe...
4 Years - 25 Years City of Hope Medical Center View Cancer Genetic Testing in Ethnic Populations NCT04475640 Breast Carcinom...
Carcinoma of Un...
Central Nervous...
Digestive Syste...
Genitourinary S...
Head and Neck C...
Malignant Brain...
Malignant Femal...
Malignant Muscu...
Malignant Solid...
Skin Carcinoma
Biospecimen Col...
Genetic Testing
18 Years - Mayo Clinic View Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer NCT04067960 Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Biliary Tract C...
Clinical Stage ...
Clinical Stage ...
Malignant Brain...
Malignant Genit...
Malignant Solid...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Pancr...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Pancr...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
Genetic Testing
Quality-of-Life...
Questionnaire A...
- Mayo Clinic View Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy NCT06377696 Malignant Brain...
Best Practice
Medical Device ...
Metformin
Neurocognitive ...
Questionnaire A...
18 Years - Mayo Clinic View Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery NCT03510208 Malignant Brain...
Malignant Gliom...
Near-Infrared F...
Panitumumab
Panitumumab-IRD...
POINPOINT-IR900...
18 Years - Stanford University View Cancer Genetic Testing in Ethnic Populations NCT04475640 Breast Carcinom...
Carcinoma of Un...
Central Nervous...
Digestive Syste...
Genitourinary S...
Head and Neck C...
Malignant Brain...
Malignant Femal...
Malignant Muscu...
Malignant Solid...
Skin Carcinoma
Biospecimen Col...
Genetic Testing
18 Years - Mayo Clinic View Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial NCT06132685 Low Grade Gliom...
Malignant Brain...
Malignant Brain...
Meningioma
Biospecimen Col...
Computed Tomogr...
Dexamethasone
Magnetic Resona...
Questionnaire A...
18 Years - Emory University View